MedTrace Logo

Anatomical-Clinical Base of Adenocarcinoma Pancreatic

NCT06128343 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1500

Last updated 2026-03-19

No results posted yet for this study

Summary

BACAP-2 is a prospective biobank dedicated to the pancreatic adenocarcinoma including clinical data and biological samples from tumor. The aim is to enrich the previous propective collection BACAP in order to support future research projects.

Conditions

  • Adenocarcinoma
  • Carcinoma
  • Neoplasms

Interventions

OTHER

collection of biological samples

Collection of biological samples including whole blood and micro-biopsy from tissue of pancreas

Sponsors & Collaborators

  • University Hospital, Toulouse

    lead OTHER

Principal Investigators

  • Barbara BOURNET, MD, PhD · University Hospital, Toulouse

Eligibility

Min Age
18 Years
Max Age
120 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-11-16
Primary Completion
2035-01-31
Completion
2035-02-28

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06128343 on ClinicalTrials.gov